Similar Tracks
Practical Symposium | JAK Inhibitor Therapy for Dermatologic Disorders by Neal Bhatia, MD
Cockerell Dermatopathology
Tofacitinib | JAK (Janus Kinase Pathway) Inhibitor Tofacitinib - pharmacology, mechanism of action.
Animated biology With arpan
JAK Inhibitor Treatment for Alopecia Areata: Understanding Side Effects and Monitoring
National Alopecia Areata Foundation
Dr. Emma Guttman discussed JAK Inhibitors and Skin Biomarkers at the EAACI World Congress 2024
Icahn School of Medicine
New Treatment for Alopecia Areata: How Deuruxolitinib Works to Regrow Hair │ Pharmacology
Pharmacology Insights
Novel Developments in treating alopecia areata: What is Type 2 inflammation and why is it important
National Alopecia Areata Foundation